Privia Health Group (NASDAQ:PRVA) CFO Sells $680,185.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 24,734 shares of the company’s stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $27.50, for a total transaction of $680,185.00. Following the sale, the chief financial officer directly owned 186,728 shares of the company’s stock, valued at approximately $5,135,020. This trade represents a 11.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total transaction of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The shares were sold at an average price of $22.60, for a total transaction of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total value of $179,690.37.

Privia Health Group Stock Up 0.1%

Shares of PRVA traded up $0.04 during midday trading on Tuesday, hitting $27.23. The company’s stock had a trading volume of 1,077,240 shares, compared to its average volume of 934,312. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $27.70. The company’s fifty day simple moving average is $23.53 and its two-hundred day simple moving average is $23.04. The stock has a market capitalization of $3.43 billion, a price-to-earnings ratio of 170.20, a price-to-earnings-growth ratio of 2.16 and a beta of 0.83.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on PRVA. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Evercore set a $26.00 target price on Privia Health Group in a research report on Wednesday, April 8th. Canaccord Genuity Group reduced their price target on Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Finally, Barclays decreased their price target on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Eleven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $31.15.

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds have recently bought and sold shares of the company. Durable Capital Partners LP lifted its holdings in Privia Health Group by 1.8% in the third quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock valued at $291,123,000 after buying an additional 203,842 shares during the period. State Street Corp raised its position in shares of Privia Health Group by 1.5% in the 2nd quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after acquiring an additional 61,853 shares in the last quarter. Van Berkom & Associates Inc. boosted its holdings in shares of Privia Health Group by 5.4% during the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after buying an additional 208,787 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Privia Health Group by 1.1% during the 4th quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company’s stock worth $66,738,000 after buying an additional 31,204 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Privia Health Group by 1.6% during the 4th quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock worth $66,099,000 after buying an additional 43,589 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.